Publicacións nas que colabora con Ricardo Blanco Alonso (70)

2024

  1. Inflammasome-Related Genetic Polymorphisms as Severity Biomarkers of COVID-19

    International Journal of Molecular Sciences, Vol. 25, Núm. 7

  2. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

2023

  1. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

    Seminars in Arthritis and Rheumatism, Vol. 58

  2. Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 910-915

  3. Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 864-869

  4. E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  5. Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  6. Epidemiology and clinical domains of Behçet's disease in the Cantabria region, Northern Spain

    Clinical and experimental rheumatology, Vol. 41, Núm. 10, pp. 1991-1997

  7. Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  8. Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study

    Clinical and experimental rheumatology, Vol. 41, Núm. 10, pp. 2105-2114

  9. Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836

  10. Reply to: New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. by Guarda et al

    Clinical and experimental rheumatology

  11. Systemic treatment in sarcoidosis: Experience over two decades

    European Journal of Internal Medicine, Vol. 108, pp. 60-67

  12. Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review

    RMD open, Vol. 9, Núm. 1

2022

  1. Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?

    Biomedicines, Vol. 10, Núm. 4

  2. Baricitinib in severe and refractory peripheral ulcerative keratitis: a case report and literature review

    Therapeutic Advances in Musculoskeletal Disease, Vol. 14

  3. Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review

    Therapeutic Advances in Musculoskeletal Disease, Vol. 14

  4. Elevated VCAM-1, MCP-1 and ADMA serum levels related to pulmonary fibrosis of interstitial lung disease associated with rheumatoid arthritis

    Frontiers in Molecular Biosciences, Vol. 9

  5. Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review

    European Journal of Internal Medicine, Vol. 101, pp. 86-92

  6. IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms

    Journal of Clinical Medicine, Vol. 11, Núm. 19